术中放射治疗市场－全球产业规模、份额、趋势、机会及预测（依产品、方法、应用、最终用户、地区及竞争格局划分），2021-2031年

全球术中放射治疗市场预计将从2025年的5,622万美元成长到2031年的7,774万美元，复合年增长率（CAGR）为5.55%。术中放射治疗（IORT）是治疗方法。其主要驱动因素包括：能够保护周围健康组织，并显着缩短治疗时间，通常可以将数週的体外放射治疗整合到一次手术中。这种高效性对于医疗系统满足激增的需求至关重要。根据世界卫生组织（WHO）国际癌症研究机构（IARC）2024年的最新估计，2022年全球将新增约2,000万例癌症病例，凸显了全球癌症负担的日益恶化。

然而，阻碍市场扩张的一大挑战在于，专用放射治疗设备和手术室维修（包括必要的屏蔽）需要大量的资金投入。此外，该技术还要求由外科医生和物理学家等高技能的多学科团队在无菌环境下密切合作，这进一步加剧了资金壁垒。这些操作上的复杂性，加上国际不同地区报销政策的不统一，限制了许多医疗机构采用术中放射治疗（IORT）技术的能力。

市场驱动因素

全球癌症病例的不断增加是推动全球术中放射线治疗市场发展的主要动力，该市场对更有效率、扩充性的治疗方法提出了更高的要求。不断增长的患者群体迫使医疗系统采用能够缩短手术等待时间和治疗时长的疗法，例如术中放射治疗（IORT），即在一次手术中即可进行聚焦放射治疗。这种需求在乳癌领域尤其突出，该领域的疾病负担正在迅速加重。国际癌症研究机构（IARC）于2025年2月在《自然医学》杂誌上发表的一项研究显示，如果目前的趋势持续下去，到2050年，全球每年新增乳癌病例将达到320万例，这凸显了快速开发治疗技术的紧迫性。

携带式和小型化术中放射治疗（IORT）系统的技术进步进一步推动了市场成长，因为它们无需昂贵的屏蔽手术室，并显着降低了医院采用这些系统的门槛。现代移动式设备能够在标准手术室内直接进行精准的放射治疗，从而提高工作流程的柔软性和营运效率。这种向普及化技术的转变也体现在产业领先创新者的财务表现。 Sensus Healthcare于2025年2月发布的「2024年第四季及全年财务表现」显示，其年度营收成长71%，达到4,180万美元，主要得益于其放射治疗产品组合的成长。同时，Carl Zeiss Meditec AG于2025年12月发布的「2024/25年度报告」显示，其总收入为22.276亿欧元，凸显了支撑这些先进解决方案的强大产业规模。

市场挑战

安装专用设备和维修手术室所需的高额资本投入是限制全球术中放射治疗市场成长的主要障碍。医疗机构需要投入大量前期资金来安装必要的屏蔽设施和购买先进的放射设备，这使得术中放射治疗的应用主要局限于资金雄厚的大规模学术机构。由于小规模医院往往缺乏预算来支持此类资本密集计划，这项限制阻碍了市场渗透。此外，在无菌环境下协调一支高技能的多学科团队的复杂操作也增加了资源压力，进一步阻碍了潜在买家的购买意愿。

报销率下降、投资回收期延长以及采用新型放射技术的经济可行性降低，加剧了这项财务挑战。据美国放射肿瘤学会 (ASTRO) 称，自 2013 年以来，根据联邦医疗保险医师收费标准，到 2025 年，放射肿瘤服务的支付额已下降了 25%。资金的持续减少使得医疗机构越来越难以证明术中系统所需巨额投资的合理性，从而直接阻碍了市场扩张。

市场趋势

临床应用拓展至神经肿瘤学和胃肠道癌症领域，显着拓宽了全球术中放射治疗市场的潜在患者群体，使其不再局限于传统的保乳治疗。医疗设备製造商正加速优化近距离近距离放射治疗方案，以治疗复杂、深部肿瘤，例如胶质母细胞瘤和脑转移瘤。在这些病例中，精准、即时的放射治疗对于预防局部復发至关重要。临床数据也支持这项转变。根据发表于《癌症网络》（CancerNetwork，2025年10月刊）的报告《胶原蛋白植入或可改善脑转移瘤的局部控制》，ROADS III期临床试验的中期结果显示，与标准立体定位放射治疗相比，伽玛射线片治疗可将新诊断脑转移瘤患者的肿瘤復发或死亡风险降低50%以上。

同时，机器人辅助术中放射治疗的出现满足了治疗位于重要血管结构附近的恶性肿瘤时对几何精度的迫切需求。透过将机器人定位系统与放射治疗设备结合，肿瘤科医生可以克服复杂的解剖结构限制，尤其是在腹部癌症的治疗中，并在最大限度地提高放射剂量适形性的同时，保护健康组织。这种技术的协同效应有望带来显着的改善。根据 News-Medical.net 网站 2025 年 10 月发表的一篇报导「初步研究证实术中放射治疗对胰腺癌转移的有效性」的文章，约翰·霍普金斯大学的研究人员报告称，利用机器人设备进行靶向术中放射治疗，可有效降低局部晚期胰腺癌患者的胰週復发率至 5%。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球术中放射治疗市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品分类（术中放射治疗设备、术中放射治疗配件、软体、服务）
  • 按方法（电子束、近距离放射、高剂量率放射治疗、X射线、其他）
  • 依应用领域（乳癌、脑瘤、头颈癌、软组织肉瘤、儿童肿瘤、妇科癌症、泌尿生殖系统癌症、其他）
  • 按最终使用者（医院/诊所、门诊护理中心、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美术中放射治疗市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

7. 欧洲术中放射治疗市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区术中放射治疗市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲术中放射治疗市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美术中放射治疗市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球术中放射治疗市场：SWOT分析

第十四章 波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• IntraOp Medical, Inc
• iCAD, Inc.
• Elekta AB
• Sensus Healthcare, Inc.
• Isoray, Inc.
• Becton, Dickinson and Company
• Sordina IORT Technologies
• Varian Medical Systems, Inc.
• SeeDos Ltd.
• IsoAid LLC

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Intraoperative Radiation Therapy Market is projected to grow from USD 56.22 Million in 2025 to USD 77.74 Million by 2031, achieving a CAGR of 5.55%. Intraoperative Radiation Therapy (IORT) involves delivering a concentrated dose of radiation directly to the tumor bed during surgery, immediately following the resection of the malignancy. Primary drivers include the clinical ability to preserve healthy surrounding tissue and the significant reduction of treatment duration, often converting weeks of external therapy into a single operative session. This efficiency is critical as healthcare systems manage escalating demand; according to the World Health Organization's International Agency for Research on Cancer, updated 2024 estimates highlighted the growing global burden with approximately 20 million new cancer cases recorded in 2022.

However, a significant challenge hindering market expansion is the high capital investment required for acquiring specialized radiation equipment and retrofitting operating rooms with necessary shielding. This financial barrier is further compounded by the stringent requirement for highly skilled multidisciplinary teams, including surgeons and physicists, to coordinate precisely within a sterile environment. These operational complexities, combined with inconsistent reimbursement policies in various international regions, limit the capacity of many healthcare facilities to adopt IORT technologies.

Market Driver

The escalating global prevalence of cancer cases acts as a primary catalyst for the Global Intraoperative Radiation Therapy Market, necessitating more efficient and scalable treatment modalities. As patient volumes rise, healthcare systems are compelled to adopt therapies that reduce surgical backlogs and treatment duration, such as IORT, which delivers concentrated radiation in a single operative session. This demand is particularly acute in breast oncology, where the burden is expanding rapidly; according to the International Agency for Research on Cancer, a study published in 'Nature Medicine' in February 2025 projected that by 2050, the annual global incidence will reach 3.2 million new breast cancer cases if current trends persist, underscoring the urgent necessity for expedited therapeutic techniques.

Technological advancements in portable and miniaturized IORT systems further propel market growth by eliminating the need for expensive, shielded operating bunkers, thereby lowering substantial adoption barriers for hospitals. Modern mobile units allow for precise radiation delivery directly in standard operating rooms, enhancing workflow versatility and operational efficiency. This shift towards accessible technology is reflected in the financial performance of key industry innovators; according to Sensus Healthcare's 'Fourth Quarter and Full Year 2024 Financial Results' from February 2025, the company reported a 71% increase in full-year revenue to $41.8 million driven by its radiation therapy portfolio, while Carl Zeiss Meditec AG's 'Annual Report 2024/25' from December 2025 showed a total revenue of €2,227.6 million, highlighting the robust industrial scale supporting these advanced solutions.

Market Challenge

The substantial capital expenditure required for acquiring specialized equipment and retrofitting operating rooms stands as a formidable barrier to the growth of the Global Intraoperative Radiation Therapy Market. Healthcare facilities face significant upfront costs to install necessary shielding and procure high-tech radiation devices, which limits adoption primarily to large, well-funded academic centers. This restriction prevents widespread market penetration, as smaller hospitals often lack the budget to support such capital-intensive projects. Additionally, the operational complexity of coordinating highly skilled multidisciplinary teams within sterile environments adds to the resource burden, further deterring potential buyers.

This financial challenge is critically aggravated by declining reimbursement rates, which extend the return on investment period and reduce the economic viability of adopting new radiation technologies. According to the American Society for Radiation Oncology in 2025, payment reductions for radiation oncology services under the Medicare Physician Fee Schedule have reached 25% since 2013. Such consistent decreases in financial support make it increasingly difficult for healthcare providers to justify the heavy investment needed for intraoperative systems, thereby directly stifling market expansion.

Market Trends

The expansion of clinical applications to neuro-oncology and gastrointestinal cancers is significantly broadening the addressable patient base for the Global Intraoperative Radiation Therapy Market beyond its traditional stronghold in breast conservation. Medical device manufacturers are increasingly tailoring brachytherapy solutions to treat complex, deep-seated tumors such as glioblastomas and brain metastases, where precise, immediate radiation is crucial to prevent local failure. This shift is supported by clinical data; according to the 'Collagen Implant May Improve Local Control of Metastatic Brain Tumors' report in CancerNetwork (October 2025), interim findings from the Phase 3 ROADS trial indicated that GammaTile therapy reduced the risk of tumor recurrence or death by more than 50% compared to standard stereotactic radiotherapy in patients with newly diagnosed brain metastases.

Simultaneously, the emergence of robotic-assisted intraoperative radiation delivery is addressing the critical need for geometric precision when treating malignancies located near vital vascular structures. The integration of robotic positioning systems with radiation delivery devices allows oncologists to navigate difficult anatomical constraints, particularly in abdominal cancers, maximizing dose conformity while sparing healthy tissue. This technological synergy is demonstrating remarkable improvements; according to the 'Preliminary study shows intraoperative radiation's success against pancreatic cancer spread' article on News-Medical.net (October 2025), investigators at Johns Hopkins reported that utilizing a robotic device for targeted intraoperative radiation effectively reduced the recurrence rate around the pancreas to just 5% in patients with locally advanced pancreatic cancer.

Key Market Players

• IntraOp Medical, Inc
• iCAD, Inc.
• Elekta AB
• Sensus Healthcare, Inc.
• Isoray, Inc.
• Becton, Dickinson and Company
• Sordina IORT Technologies
• Varian Medical Systems, Inc.
• SeeDos Ltd.
• IsoAid LLC

Report Scope

In this report, the Global Intraoperative Radiation Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Intraoperative Radiation Therapy Market, By Product

• Intraoperative Radiation Therapy Devices
• Intraoperative Radiation Therapy Accessories
• Software
• Services

Intraoperative Radiation Therapy Market, By Method

• Electron
• Intraoperative Brachytherapy
• High Dose-Rate
• X-Ray
• Others

Intraoperative Radiation Therapy Market, By Application

• Breast Cancer
• Brain Tumor
• Head and Neck Cancer
• Soft Tissue Sarcoma
• Pediatric Tumors
• Gynecological Cancer
• Genitourinary Cancers
• Others

Intraoperative Radiation Therapy Market, By End User

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Intraoperative Radiation Therapy Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Intraoperative Radiation Therapy Market.

Available Customizations:

Global Intraoperative Radiation Therapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Intraoperative Radiation Therapy Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Intraoperative Radiation Therapy Devices, Intraoperative Radiation Therapy Accessories, Software, Services)
  • 5.2.2. By Method (Electron, Intraoperative Brachytherapy, High Dose-Rate, X-Ray, Others)
  • 5.2.3. By Application (Breast Cancer, Brain Tumor, Head and Neck Cancer, Soft Tissue Sarcoma, Pediatric Tumors, Gynecological Cancer, Genitourinary Cancers, Others)
  • 5.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Intraoperative Radiation Therapy Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Method
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Intraoperative Radiation Therapy Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Method
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Intraoperative Radiation Therapy Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Method
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Intraoperative Radiation Therapy Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Method
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Intraoperative Radiation Therapy Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Method
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Intraoperative Radiation Therapy Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Method
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. France Intraoperative Radiation Therapy Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Method
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Intraoperative Radiation Therapy Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Method
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Intraoperative Radiation Therapy Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Method
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Intraoperative Radiation Therapy Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Method
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia Pacific Intraoperative Radiation Therapy Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Method
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Intraoperative Radiation Therapy Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Method
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Intraoperative Radiation Therapy Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Method
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Intraoperative Radiation Therapy Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Method
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Intraoperative Radiation Therapy Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Method
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Intraoperative Radiation Therapy Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Method
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. Middle East & Africa Intraoperative Radiation Therapy Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Method
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Intraoperative Radiation Therapy Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Method
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Intraoperative Radiation Therapy Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Method
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Intraoperative Radiation Therapy Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Method
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. South America Intraoperative Radiation Therapy Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Method
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Intraoperative Radiation Therapy Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Method
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Intraoperative Radiation Therapy Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Method
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Intraoperative Radiation Therapy Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Method
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Intraoperative Radiation Therapy Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. IntraOp Medical, Inc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. iCAD, Inc.
• 15.3. Elekta AB
• 15.4. Sensus Healthcare, Inc.
• 15.5. Isoray, Inc.
• 15.6. Becton, Dickinson and Company
• 15.7. Sordina IORT Technologies
• 15.8. Varian Medical Systems, Inc.
• 15.9. SeeDos Ltd.
• 15.10. IsoAid LLC

16. Strategic Recommendations

17. About Us & Disclaimer